Allen Nissenson - 19 May 2022 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Allen Nissenson
Issuer symbol: ELTX
Transactions as of: 19 May 2022
Net transactions value: +$10,925
Form type: 4
Filing time: 23 May 2022, 19:48:38 UTC
Previous filing: 22 Jun 2021
Next filing: 09 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$8,521	+7,346		$1.16^*	7,346	19 May 2022	Direct	F1
transaction	ELTX	Common Stock	Purchase	$2,404	+2,037	+28%	$1.18^*	9,383	20 May 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.